BBC vs VTI
Virtus LifeSci Biotech Clinical Trials ETF vs Vanguard Morningstar Total Stock Market ETF
Which is better, BBC or VTI?
Small Cap Growth against Large Cap Blend.
VTI has a lower expense ratio. BBC led over 1Y and 3Y, VTI over 5Y and the full window. BBC is less concentrated, with 12.3% of the fund in its ten largest positions against 33.3%.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | BBC | VTI |
|---|---|---|
| Expense Ratio | 0.65% | 0.03%Best |
| AUM | $50M | $666.9B |
| Dividend Yield | 1.24% | 1.03% |
| Holdings | 132 | 3,543 |
| YTD Return | +29.17%Best | +12.30% |
| 1Y Return | +95.71%Best | +16.08% |
| 3Y Return (annualized) | +34.63%Best | +21.01% |
| 5Y Return (annualized) | +1.41% | +12.36%Best |
| Volatility (annualized) | 35.9% | 15.4%Best |
| Max Drawdown | -76.8% | -35.0%Best |
| $10,000 over 5 years | $10,725 | $17,908Best |
| Top 10 Weight | 12.3%Best | 33.3% |
| Fund Family | Virtus Investment Partners | Vanguard (US) |
| Category | Equity | Equity |
| Style | Small Cap Growth | Large Cap Blend |
| Inception | Dec 16, 2014 | May 24, 2001 |
Volatility and max drawdown are measured over the window both funds cover: Dec 17, 2014 to Sep 18, 2026 (11.8 years).
BBC vs VTI growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 11.8 years both funds cover.
BBC vs VTI Performance
Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an ETF from Virtus Investment Partners and Vanguard Morningstar Total Stock Market ETF (VTI) is an ETF from Vanguard (US). Over the past year BBC returned +95.71% while VTI returned +16.08%. Year to date, BBC is up 29.17% versus a gain of 12.30% for VTI.
Over three years, BBC compounded at +34.63% per year against +21.01% for VTI; over five years the annualized figures are +1.41% and +12.36% respectively. Across the full 12-year window we track, VTI has the edge at +12.27% annualized vs +5.74%.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
BBC has been the more volatile fund, with annualized monthly volatility of 35.9% compared with 15.4% for VTI. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -76.8% for BBC and -35.0% for VTI. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.53. They move together some of the time, and apart the rest.
Fees and Cost Over Time
BBC charges 0.65% per year while VTI charges 0.03%. On a $10,000 position that is $65 vs $3 annually, a gap of $62 per year that compounds over a long holding period. On income, BBC currently yields 1.24% against 1.03% for VTI.
Holdings Overlap
80.4% of BBC's money is in holdings VTI also owns. 0.2% of VTI's money is in holdings BBC also owns.
Most of BBC is already inside VTI. Owning both mostly buys the same companies twice.
105 positions in common, counted across the 130 positions we hold weights for in BBC and 3,463 in VTI, against full books of 132 and 3,543.
What only one of them owns
Our book lists 1,134 positions for VTI that do not appear in our book for BBC (97.3% of the fund), and 12 for BBC that do not appear in VTI (9.2%).
Some of those will be the same company recorded under a different code in one of the two books, so the real difference in what you would own is no larger than this and may be smaller. We do not name the individual positions here for that reason.
Top Shared Holdings
| Stock | Weight in BBC | Weight in VTI | Difference |
|---|---|---|---|
| TRAXFirst Tracks Biotherapeutics, Inc. | 1.49% | 0.00% | 1.49% |
| AMLXAmylyx Pharmaceuticals Inc | 1.44% | 0.00% | 1.44% |
| XNCRXencor Inc | 1.33% | 0.00% | 1.33% |
| MNPRMonopar Therapeutics Inc | 1.22% | 0.00% | 1.22% |
| SLSSellas Life Sciences Group Inc. | 1.08% | 0.00% | 1.08% |
| MBXMbx Biosciences Inc | 1.07% | 0.00% | 1.07% |
| REPLReplimune Group Inc Com | 1.06% | 0.00% | 1.06% |
| ANROAlto Neuroscience, Inc., Series C | 1.05% | 0.00% | 1.05% |
| VORVor Biopharma Inc | 1.04% | 0.00% | 1.04% |
| FDMT4d Molecular Therapeutics Inc. | 1.03% | 0.00% | 1.03% |
80.4% of BBC is already inside VTI.
You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, BBC or VTI?
BBC has an expense ratio of 0.65% while VTI charges 0.03%. VTI is the cheaper option, by $62 a year on a $10,000 investment.
Which performed better, BBC or VTI?
Over the past year BBC returned +95.71% vs +16.08% for VTI, so BBC leads on 1-year performance. Over the longest common window we track (12 years), BBC annualized +5.74% vs +12.27% for VTI. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, BBC or VTI?
BBC has been the more volatile fund at 35.9% annualized versus 15.4% for VTI. Worst drawdown: BBC -76.8% vs VTI -35.0%.
Should I hold both BBC and VTI?
BBC and VTI have a monthly-return correlation of 0.53, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
What is the holdings overlap between BBC and VTI?
80.4% of BBC's money is in holdings VTI also owns. 0.2% of VTI's is in holdings BBC also owns. They hold 105 positions in common, counted across the 130 positions we hold weights for in BBC and 3,463 in VTI.
Which pays a higher dividend, BBC or VTI?
BBC yields 1.24% while VTI yields 1.03%, so BBC currently pays the higher dividend yield.
Is VTI better than BBC?
VTI has a lower expense ratio. BBC led over 1Y and 3Y, VTI over 5Y and the full window. BBC is less concentrated, with 12.3% of the fund in its ten largest positions against 33.3%. Which one suits a particular account depends on what it is for. This is information, not a recommendation.